Delivery Order SPE2DB24D2212-SPE2DB25FHQUD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,723.61 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 200 mg/mL. This firm fixed-price, non-set-aside contract was awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,569.66 for Testosterone Cypionate 200 mg/mL on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price, competitively awarded delivery order represents a continuation of pharmaceutical supply services to support federal medical procurement needs. The contract was not issued under any set-aside program and will be performed at the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $1,786.65 delivery order to AmerisourceBergen Drug Corp for Testosterone Cypionate 200 mg/mL on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price contract, issued without set-aside designation, represents a competitive award executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle running through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $1,463.30 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 200 mg/mL on September 13, 2025, with an ultimate completion date of September 15, 2025. This non-competitive, firm fixed-price delivery order is performed at the contractor's Conshohocken, Pennsylvania location and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The award is issued...
- The Defense Logistics Agency awarded a $1,416 delivery order to AmerisourceBergen Drug Corp for Testosterone Cypionate 200 mg/mL, with an ultimate completion date of September 15, 2025. This firm fixed-price delivery order, awarded September 12, 2025, represents a non-competitive set-aside transaction and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $2,582.10 firm fixed price delivery order to AmerisourceBergen Drug Corp for Testosterone Cypionate 200 mg/mL, effective September 10, 2025, with an ultimate completion date of September 11, 2025. This non-set-aside award represents a competitive procurement of pharmaceutical products to support federal medical supply needs. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,528.26 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 200 mg/mL on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order valued at $2,005.86 to AmerisourceBergen Drug Corp for Testosterone Cypionate 200 mg/mL on September 9, 2025, with completion scheduled for September 10, 2025. This firm fixed-price delivery order was not set-aside and represents a competitively awarded pharmaceutical supply transaction. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters and serves...
- The Defense Logistics Agency awarded a delivery order valued at $1,130.17 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 200 mg/mL. This contract, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a firm fixed-price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,761.52 on July 22, 2025, for the supply of Testosterone Cypionate 2,000 mg/10mL vials. This firm fixed-price delivery order, which is not set-aside designated, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. The award represents a single-item pharmaceutical procurement supporting military healthcare supply...
- SPE2DB24D2212Indefinite Delivery Contract
- SPE2DB24D2212-SPE2DB25FHQUDDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Testosterone Cypionate 200 mg/mL with a ceiling value of $1,586.61. This firm fixed-price delivery order, issued on September 11, 2025, is expected to be completed by September 12, 2025, and represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance and is a major pharmaceutical distributor providing critical medical supplies to federal healthcare systems, particularly the Department of Defense and military medical programs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime indefinite delivery vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare operations globally. The company's contract portfolio with DLA demonstrates its capability to fulfill diverse medical procurement requirements through open competition, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 9/11/25 |